Latest Articles about NBIX

Neurocrine draws nervous position

David Russell — Tue, 09 Apr 2013 11:06:06 Z

Neurocrine Biosciences has rallied back to resistance, but one investor is worried about a pullback. optionMONSTER's Depth Charge monitoring program detected the purchase of 2,000 August 9

Elagolix Enters Phase 3 - Analyst Blog

Zacks Equity Research — Wed, 06 Jun 2012 21:14:01 Z

Elagolix Enters Phase 3 By Jason Napodano, CFA On June 5, 2012, Abbott Labs (NYSE: ABT ) and Neurocrine Biosciences (NASDAQ: NBIX ) announced that they had initiated a pivotal

Largest option buying in equities so far

David Russell — Thu, 15 Mar 2012 20:21:28 Z

Nearing the halfway mark in today's session, here are the individual equity names with the most call and put buying on optionMONSTER's ActionTracker data system. Bank of America (BAC):

Profit Ideas: 10 High-Growth Stocks with Strong Sources of Profitability

Kapitall — Fri, 16 Dec 2011 05:19:40 Z

( List compiled by Rebecca Lipman. ROE data sourced from Google Finance. All other data sourced from Finviz.) Looking for profitable companies that show promise down the road? For this list

Insomnia Found to Cost $63 Billion a Year - Here are 4 Companies to Treat It

Kapitall — Wed, 12 Oct 2011 03:09:06 Z

( By Alexander Crawford ) According to a recent study , insomnia costs the average US worker 11.3 days in productivity (about $2,280) every year, amounting to $63 billion annually. This

Brain Disorders: 3 Biotech Stocks at the Forefront

Kapitall — Thu, 06 Oct 2011 07:43:32 Z

(Written by Alexander Crawford. Data sourced from Finviz.) A new study by the European Brain Council (EBC) found that the cost of mental and neurological disorders in Europe is far outpacing

5 Earnings Studs & 5 Duds

Louis Navellier — Wed, 30 Mar 2011 19:35:00 Z

Earnings season is an exciting time for investors as it is during these periods that fundamentally superior stocks rack up their biggest gains. What I look for every earnings season is stocks

Neurocrine seen running out of gas

David Russell — Wed, 27 Oct 2010 21:27:45 Z

Neurocrine Biosciences has made a big move, and now the bulls are throwing in the towel. optionMONSTER's tracking programs detected the sale of about 2,000 February 9 calls for $0.80

Thursday Winners: Neurocrine Biosciences, Pier One and Winnebago

David Sterman — Thu, 17 Jun 2010 19:06:21 Z

Among the biggest winners in Thursday's early trading are Neurocrine Biosciences, (Nasdaq: NBIX) , Pier One ( PIR ) and Winnebago ( WGO ) .

Neurocrine rally met with call sellers

David Russell — Thu, 17 Jun 2010 16:05:34 Z

Neurocrine Biosciences ripped to a 22-month high yesterday, leading traders to take profits. optionMONSTER's tracking systems detected heavy selling of the June 5 calls for $0.50 and

Wednesday Winners: Neurocrine Biosciences, Sunoco and Ener1

David Sterman — Wed, 16 Jun 2010 20:16:17 Z

Among the biggest winners in Wednesday's early trading are Neurocrine Biosciences (Nasdaq: NBIX) , Sunoco ( SUN ) and Ener1 ( HEV ) . Top

Tuesday Winners: Neurocrine Biosciences, USEC and Capstone Turbine

David Sterman — Tue, 25 May 2010 19:59:32 Z

Among the winners in Tuesday's early trading are Neurocrine Biosciences (Nasdaq: NBIX) , USEC ( USU ) and Capstone Turbine (Nasdaq: CPST) .